Igyxos Biotherapeutics
PrivateLast Round
Grant
Oct 2, 2025
Total Funding Raised
$20.58M
Company Overview
Igyxos Biotherapeutics is a biotechnology company that develops monoclonal antibody-based therapeutics to treat infertility in men and women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igyxos Biotherapeutics Comparables
Compare Igyxos Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxolife | 78% | |
| Granata Bio | 76% | |
| Merck | 73% |
Igyxos Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 2, 2025 | ||||
| VC Round | Nov 14, 2023 | ||||
| Debt | Nov 14, 2023 | ||||
| Series A | Mar 21, 2019 |
Key People
Founding team and executive leadership
Igyxos Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Social Impact Enterprises | VC Round |
| Sofimac Innovation | Series A |
| GO Capital | VC Round, Series A |
| Sofimac Investment Managers | VC Round |
| Bpifrance | Debt, VC Round, Grant, Series A |
| UI Investissement | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 1871% MoM, reaching 2.5K.
- Nov 14, 2023
$12.3M raised from Sofimac, UI Investissement, GO Capital, Bpifrance, and Social Impact Enterprises.
Igyxos Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Igyxos Biotherapeutics's valuation, stock price, and market status.
Is Igyxos Biotherapeutics a public or private company?
Igyxos Biotherapeutics is a private company.
What is the current stock price of Igyxos Biotherapeutics?
Igyxos Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Igyxos Biotherapeutics worth (valuation)?
Valuation information for Igyxos Biotherapeutics is not publicly available.
Can I buy Igyxos Biotherapeutics stock?
Igyxos Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Igyxos Biotherapeutics's last funding round?
Igyxos Biotherapeutics's most recent funding round was Grant on October 2, 2025.
Who are the main investors in Igyxos Biotherapeutics?
Key investors in Igyxos Biotherapeutics include Bpifrance.
Will Igyxos Biotherapeutics IPO soon?
No public IPO plans have been announced for Igyxos Biotherapeutics.
How can I track Igyxos Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Igyxos Biotherapeutics's secondary market activity and sign up for updates.